It was great to connect with Celltrion at the Capitol after visiting their Branchburg, NJ facility earlier this year.
I heard about the progress they're making on manufacturing, research, and development, and what more can be done to enhance investment in New Jersey.
I heard about the progress they're making on manufacturing, research, and development, and what more can be done to enhance investment in New Jersey.
August 8, 2026 at 9:51 PM
It was great to connect with Celltrion at the Capitol after visiting their Branchburg, NJ facility earlier this year.
I heard about the progress they're making on manufacturing, research, and development, and what more can be done to enhance investment in New Jersey.
I heard about the progress they're making on manufacturing, research, and development, and what more can be done to enhance investment in New Jersey.
Celltrion unit pays $330 million for Eli Lilly production facility, filing shows reut.rs/4nhTdAn
Celltrion unit pays $330 million for Eli Lilly production facility, filing shows
Celltrion Inc. said in a regulatory filing in South Korea on Tuesday its U.S. subsidiary has acquired Imclone Systems LLC from Eli Lilly in the United States for $330 million.
reut.rs
September 23, 2025 at 1:40 AM
Celltrion unit pays $330 million for Eli Lilly production facility, filing shows reut.rs/4nhTdAn
Today, I joined Celltrion for the opening of their facility in Branchburg, NJ.
This is what the Einstein Corridor is all about: global innovation in medicine and technology that starts right here in our state. It’s an exciting time to be a New Jerseyan!
This is what the Einstein Corridor is all about: global innovation in medicine and technology that starts right here in our state. It’s an exciting time to be a New Jerseyan!
January 5, 2026 at 8:25 PM
Today, I joined Celltrion for the opening of their facility in Branchburg, NJ.
This is what the Einstein Corridor is all about: global innovation in medicine and technology that starts right here in our state. It’s an exciting time to be a New Jerseyan!
This is what the Einstein Corridor is all about: global innovation in medicine and technology that starts right here in our state. It’s an exciting time to be a New Jerseyan!
Health Canada says it is working to reduce backlog of lower-cost biosimilar drug submissions https://www.theglobeandmail.com/business/economy/article-health-canada-says-it-is-working-to-reduce-backlog-of-lower-cost/
𝗠𝗼𝗿𝗲 𝗻𝗲𝘄𝘀 ⇢ CanadaHealthwatch.ca 🍁
𝗠𝗼𝗿𝗲 𝗻𝗲𝘄𝘀 ⇢ CanadaHealthwatch.ca 🍁
September 4, 2025 at 10:57 PM
Health Canada says it is working to reduce backlog of lower-cost biosimilar drug submissions https://www.theglobeandmail.com/business/economy/article-health-canada-says-it-is-working-to-reduce-backlog-of-lower-cost/
𝗠𝗼𝗿𝗲 𝗻𝗲𝘄𝘀 ⇢ CanadaHealthwatch.ca 🍁
𝗠𝗼𝗿𝗲 𝗻𝗲𝘄𝘀 ⇢ CanadaHealthwatch.ca 🍁
Find insight on Bayer, Celltrion, Sartorius and more in the latest Market Talks covering Health Care. on.wsj.com/47xBGhy
Health Care Roundup: Market Talk
Find insight on Bayer, Celltrion, Sartorius and more in the latest Market Talks covering Health Care.
on.wsj.com
March 17, 2026 at 11:48 AM
Find insight on Bayer, Celltrion, Sartorius and more in the latest Market Talks covering Health Care. on.wsj.com/47xBGhy
Hot tip from @lizwhatsherface.bsky.social on some affordable rapid tests. Not a bad time to grab some 😭
rtmedhealth.com/usa/product/...
rtmedhealth.com/usa/product/...
Celltrion DiaTrust COVID-19 Antigen Rapid Test (Box of 25) | RT Medical
Purchase the Celltrion DiaTrust™ COVID-19 Ag Home Test. It is a fast, proven, and trusted test you can perform in the comfort of your home.
rtmedhealth.com
September 10, 2023 at 10:19 AM
Hot tip from @lizwhatsherface.bsky.social on some affordable rapid tests. Not a bad time to grab some 😭
rtmedhealth.com/usa/product/...
rtmedhealth.com/usa/product/...
WellsCare and Celltrion Canada Join Forces to Revolutionize Pain Management Technology#South_Korea#Seoul#Celltrion#WellsCare#IASO
WellsCare and Celltrion Canada Join Forces to Revolutionize Pain Management Technology
WellsCare partners with Celltrion Canada to launch innovative pain relief technology across North America, enhancing patient care.
third-news.com
October 20, 2025 at 1:47 PM
WellsCare and Celltrion Canada Join Forces to Revolutionize Pain Management Technology#South_Korea#Seoul#Celltrion#WellsCare#IASO
Kaigene and Celltrion Forge Alliance to Develop Innovative Antibody Therapies for Autoimmune Disorders#United_States#Rockville#Celltrion#antibody_therapeutics#Kaigene
Kaigene and Celltrion Forge Alliance to Develop Innovative Antibody Therapies for Autoimmune Disorders
Kaigene has signed a licensing deal with Celltrion to develop advanced antibody therapeutics targeting autoimmune diseases, opening new avenues for treatment.
third-news.com
November 4, 2025 at 12:10 AM
Kaigene and Celltrion Forge Alliance to Develop Innovative Antibody Therapies for Autoimmune Disorders#United_States#Rockville#Celltrion#antibody_therapeutics#Kaigene
A new tocilizumab (Actemra®) biosimilar has entered the market with IV and SC formulations approved for #rheumatoidArthritis, juvenile idiopathic #arthritis, #COVID19, and giant cell arteritis. #rheumatology #autoimmune
Celltrion
2025.01.31
buff.ly
February 6, 2025 at 4:03 PM
A new tocilizumab (Actemra®) biosimilar has entered the market with IV and SC formulations approved for #rheumatoidArthritis, juvenile idiopathic #arthritis, #COVID19, and giant cell arteritis. #rheumatology #autoimmune
South Korea's Celltrion pays $330m for Eli Lilly factory in US
https://asia.nikkei.com/business/business-deals/south-korea-s-celltrion-pays-330m-for-eli-lilly-factory-in-us
https://asia.nikkei.com/business/business-deals/south-korea-s-celltrion-pays-330m-for-eli-lilly-factory-in-us
South Korea's Celltrion pays $330m for Eli Lilly factory in US
Drugmaker aims to complete acquisition process by year-end
asia.nikkei.com
September 23, 2025 at 4:06 AM
South Korea's Celltrion pays $330m for Eli Lilly factory in US
https://asia.nikkei.com/business/business-deals/south-korea-s-celltrion-pays-330m-for-eli-lilly-factory-in-us
https://asia.nikkei.com/business/business-deals/south-korea-s-celltrion-pays-330m-for-eli-lilly-factory-in-us
Here but looks like they’re sold out for now at least rtmedhealth.com/usa/product/...
Celltrion DiaTrust COVID-19 Antigen Rapid Test (Box of 25) | RT Medical
Purchase the Celltrion DiaTrust™ COVID-19 Ag Home Test. It is a fast, proven, and trusted test you can perform in the comfort of your home.
rtmedhealth.com
December 28, 2023 at 5:26 AM
Here but looks like they’re sold out for now at least rtmedhealth.com/usa/product/...
💥 What happens when your $7B drug becomes fair game?
Tanvex , Henlius, Teva, Biocon, Celltrion.
The 2025 biosimilar wave is global, aggressive, and built for impact.
♻️ Repost
👉 Follow @sbokhiria.bsky.social
#biosimilars #oncology #fda #ema #kiriaresearch
Tanvex , Henlius, Teva, Biocon, Celltrion.
The 2025 biosimilar wave is global, aggressive, and built for impact.
♻️ Repost
👉 Follow @sbokhiria.bsky.social
#biosimilars #oncology #fda #ema #kiriaresearch
June 18, 2025 at 3:54 PM
💥 What happens when your $7B drug becomes fair game?
Tanvex , Henlius, Teva, Biocon, Celltrion.
The 2025 biosimilar wave is global, aggressive, and built for impact.
♻️ Repost
👉 Follow @sbokhiria.bsky.social
#biosimilars #oncology #fda #ema #kiriaresearch
Tanvex , Henlius, Teva, Biocon, Celltrion.
The 2025 biosimilar wave is global, aggressive, and built for impact.
♻️ Repost
👉 Follow @sbokhiria.bsky.social
#biosimilars #oncology #fda #ema #kiriaresearch
Thank you to Celltrion Healthcare UK for welcoming me to their new offices in Uxbridge.
It’s great to welcome them to Hillingdon!
I look forward to working with them and other medical research organisations to make sure we continue to innovate and get people the new treatments they need 💊
It’s great to welcome them to Hillingdon!
I look forward to working with them and other medical research organisations to make sure we continue to innovate and get people the new treatments they need 💊
August 22, 2025 at 6:47 PM
Thank you to Celltrion Healthcare UK for welcoming me to their new offices in Uxbridge.
It’s great to welcome them to Hillingdon!
I look forward to working with them and other medical research organisations to make sure we continue to innovate and get people the new treatments they need 💊
It’s great to welcome them to Hillingdon!
I look forward to working with them and other medical research organisations to make sure we continue to innovate and get people the new treatments they need 💊
Celltrion's YUFLYMA® Receives Expanded FDA Interchangeability Designation#None#Celltrion#Humira#YUFLYMA
Celltrion's YUFLYMA® Receives Expanded FDA Interchangeability Designation
Celltrion, Inc. proudly announces that its biosimilar YUFLYMA® has received expanded FDA interchangeability designation for all its dosage forms, improving patient access.
third-news.com
May 22, 2025 at 12:25 AM
Celltrion's YUFLYMA® Receives Expanded FDA Interchangeability Designation#None#Celltrion#Humira#YUFLYMA
"Celltrion files Keytruda biosimilar in Korea, eyes US, Europe next"
#medsky #healthcare #hospice #healthpolicy #homehealth
#medsky #healthcare #hospice #healthpolicy #homehealth
Celltrion files Keytruda biosimilar in Korea, eyes US, Europe next
Celltrion said Monday it has applied to the Ministry of Food and Drug Safety (MFDS) for approval of CT-P51, a biosimilar candidate to MSD’s blockbuster cancer immunotherapy Keytruda (pembrolizumab).The application covers major indications of Keytruda, including non-small cell lung cancer (NSCLC), me
www.koreabiomed.com
August 24, 2026 at 8:00 AM
"Celltrion files Keytruda biosimilar in Korea, eyes US, Europe next"
#medsky #healthcare #hospice #healthpolicy #homehealth
#medsky #healthcare #hospice #healthpolicy #homehealth
#Celltrion chairman Seo Jung-jin returned to lead the shareholder meeting after 11 years, outlining expansion plans, investment strategy and outlook amid global uncertainty.
Read more: buff.ly/ayMYb6R
#Korea #Biotech #Pharma
Read more: buff.ly/ayMYb6R
#Korea #Biotech #Pharma
Celltrion chairman says firm safe from global instability at shareholder meeting
Seo Jung-jin, chairman of Celltrion Group, returned as chair of the biopharmaceutical's general shareholder meeting for the first time in 11 years on Tuesday, outlining plans to respond to global…
koreajoongangdaily.joins.com
March 24, 2026 at 9:18 AM
#Celltrion chairman Seo Jung-jin returned to lead the shareholder meeting after 11 years, outlining expansion plans, investment strategy and outlook amid global uncertainty.
Read more: buff.ly/ayMYb6R
#Korea #Biotech #Pharma
Read more: buff.ly/ayMYb6R
#Korea #Biotech #Pharma
#PHILANTROPIE | 🔎🩺 Un nouveau professorat pour la recherche sur les maladies inflammatoires de l’intestin
Grâce à un don de Celltrion Healthcare Canada, la Faculté de médecine de l’Université de Montréal créera le Professorat de recherche Celltrion sur les maladies inflammatoires de l’intestin. 👇
Grâce à un don de Celltrion Healthcare Canada, la Faculté de médecine de l’Université de Montréal créera le Professorat de recherche Celltrion sur les maladies inflammatoires de l’intestin. 👇
Un nouveau professorat pour la recherche sur les maladies inflammatoires de l’intestin - Faculté de médecine
Grâce à un don de Celltrion Healthcare Canada, un professorat de recherche consacré aux maladies inflammatoires de l’intestin sera créé à la Faculté de médecine. Les maladies inflammatoires de l’intes...
bit.ly
June 16, 2026 at 4:55 PM
#PHILANTROPIE | 🔎🩺 Un nouveau professorat pour la recherche sur les maladies inflammatoires de l’intestin
Grâce à un don de Celltrion Healthcare Canada, la Faculté de médecine de l’Université de Montréal créera le Professorat de recherche Celltrion sur les maladies inflammatoires de l’intestin. 👇
Grâce à un don de Celltrion Healthcare Canada, la Faculté de médecine de l’Université de Montréal créera le Professorat de recherche Celltrion sur les maladies inflammatoires de l’intestin. 👇
Celltrion commenced operations at its newly completed third plant situated in Songdo, Incheon, the Korean drugmaker said on Thursday.
December 5, 2024 at 8:58 AM
Celltrion commenced operations at its newly completed third plant situated in Songdo, Incheon, the Korean drugmaker said on Thursday.
rtmedhealth.com/usa/product/... on sale for $1/test!
Celltrion DiaTrust COVID-19 Antigen Rapid Test (Box of 25) | RT Medical
Purchase the Celltrion DiaTrust™ COVID-19 Ag Home Test. It is a fast, proven, and trusted test you can perform in the comfort of your home.
rtmedhealth.com
September 10, 2023 at 2:42 PM
rtmedhealth.com/usa/product/... on sale for $1/test!
According to industry sources, owner successors of leading Korean biotech firms drew significant attention as they stepped forward at the 44th JPMorgan Healthcare Conference held recently in San Francisco.
#JPMorgan #JPMHC #Celltrion #Lotte #SK #bio #it #itchosun #chosun #SouthKorea #Korea
#JPMorgan #JPMHC #Celltrion #Lotte #SK #bio #it #itchosun #chosun #SouthKorea #Korea
Next-Generation Leaders of K-Bio Put to the Test at JPMorgan
As owner heirs of major Korean biotech companies took center stage at the JPMorgan Healthcare Conference (JPMHC)—the world’s largest pharmaceutical and biotech
it.chosun.com
January 20, 2026 at 5:03 AM
[3/4] construction of NAND and advanced packaging plants; biopharmaceutical company Celltrion plans to invest approximately 2 trillion won in biopharmaceutical facilities. In addition, about 150 trillion won will flow to AI data centers. The Korean government has
July 2, 2026 at 2:44 AM
[3/4] construction of NAND and advanced packaging plants; biopharmaceutical company Celltrion plans to invest approximately 2 trillion won in biopharmaceutical facilities. In addition, about 150 trillion won will flow to AI data centers. The Korean government has
3rd Actemra biosimilar was approved by FDA - Celltrion announced approval of Avtozma (CT-P47, tocilizumab-anoh); both IV & SCm for Rx of RA, GCA, pJIA, Still's dz & Covid-19. Joins other IL-6 biosimilars Tofidence (Biogen 10/23) & Tyenne (Frensius 3/24)
Celltrion’s Avtozma, a biosimilar to Actemra receives US FDA approval to treat RA, GCA, pJIA, sJIA and Covid-19
Celltrion, a leading biopharmaceutical company based in Incheon, South Korea, announced that the US Food and Drug Administration (FDA) has approved Avtozma (CT-P47, tocilizumab-anoh) in both an…
buff.ly
February 3, 2025 at 7:00 PM
3rd Actemra biosimilar was approved by FDA - Celltrion announced approval of Avtozma (CT-P47, tocilizumab-anoh); both IV & SCm for Rx of RA, GCA, pJIA, Still's dz & Covid-19. Joins other IL-6 biosimilars Tofidence (Biogen 10/23) & Tyenne (Frensius 3/24)
"Celltrion expands Asia presence as key products retain market lead"
#medsky #healthcare #hospice #healthpolicy #homehealth
#medsky #healthcare #hospice #healthpolicy #homehealth
Celltrion expands Asia presence as key products retain market lead
Celltrion said Wednesday that the company is strengthening its presence in Asia, a key growth market for the pharmaceutical industry, as its major autoimmune and oncology products continue to expand their market shares across the region.The company operates direct sales networks through local subsid
www.koreabiomed.com
August 19, 2026 at 4:00 AM
"Celltrion expands Asia presence as key products retain market lead"
#medsky #healthcare #hospice #healthpolicy #homehealth
#medsky #healthcare #hospice #healthpolicy #homehealth
"Celltrion’s CT-P73 wins FDA Fast Track status for cervical cancer"
#medky #healthcare #hospice #healthpolicy #homehealth
#medky #healthcare #hospice #healthpolicy #homehealth
Celltrion’s CT-P73 wins FDA Fast Track status for cervical cancer
Celltrion said Thursday that its antibody-drug conjugate (ADC) cancer drug candidate CT-P73 has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for recurrent or metastatic cervical cancer.The designation means all three of Celltrion’s ADC candidates currently in phas
www.koreabiomed.com
August 13, 2026 at 2:03 PM
"Celltrion’s CT-P73 wins FDA Fast Track status for cervical cancer"
#medky #healthcare #hospice #healthpolicy #homehealth
#medky #healthcare #hospice #healthpolicy #homehealth